参考文献/References:
[1] Briasoulis A,Afonso L,Palla M,et al.Culprit-vessel versus complete revascularization during primary angioplasty in ST-elevation myocardial infarction:an updated meta-analysis[J].Int J Cardiol,2015,178:171-174.
[2] Widimsky P,Holmes DR Jr.How to treat patients with ST-elevation acute myocardial infarction and multi-vessel disease[J].Eur Heart J,2011,32(4):396-403.
[3] Shen WF.Primary percutaneous coronary intervention in elderly patients with ST-elevation acute myocardial infarction[J].Chin Med J(Engl),2006,119(14):1147-1150.
[4] Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation[J]. Eur Heart J,2012,33(20):2569-2619.
[5] Cuisset T,Noc M.Multivessel PCI in STEMI:ready to be the recommended strategy [J].EuroIntervention,2014,10:T47-T54.
[6] Bagai A,Thavendiranathn P,Sharieff W,et al.Non-infarct-related artery revascularization during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction:a systematic review and meta-analysis[J].Am Heart J,2013,166(4):684-693
[7] Windecker S,Kolh P,Alfonso F,et al.2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J].Eur Heart J,2014,35(37):2541-2619.
[8] O'gara PT,Kushner FG,Ausheim DD,et al.2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].J Am Coll Cardiol,2013,61(4):485-510.
[9] Bainey KR, Mehta SR, Lai T,et al.Complete vs culprit-only revascularization for patients with multivessel disease undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review and meta-analysis[J]. Am Heart J,2014,167(1):1-14.
[10] Hannan EL,Samadashvili Z,Walford G,et al.Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease[J].JACC Cardiovasc Interv,2010,3(1):22-31.
[11] Toma M, Buller CE, Westerhout CM, et al.Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial[J]. Eur Heart J,2010,31(14):1701-1707.
[12] 沈迎, 张瑞岩,沈卫峰,等.急性 ST 段抬高心肌梗死介入治疗策略:争议与思考[J].中国介入心脏病学杂志,2015,23:121-124.
[13] Alfonso F.Multivessel intervention during primary angioplasty:too greedy?[J].JACC Cardiovasc Interv,2010,3(1):32-34.
[14] 王健,颜红兵,郑斌,等.急诊介入治疗对非梗死相关动脉灌注的影响[J].中华急诊医学杂志,2011,20(9):971-975.
[15] Hannan EL,Wu C,Walford G,et al.Incomplete revascularization in the era of drug-eluting stents:impact on adverse outcomes[J].JACC Cardiovasc Interv,2009,2(1):17-25.
[16] Sethi A,Bahekar A,Bhuriya R,et al.Complete versus culprit-only revascularization in acute ST elevation myocardial infarction: a meta-analysis[J].Catheter Cardiovasc Interv,2011,77(2):163-170.
[17] Wald DS,Morris JK,Wald NJ,et al.Randomized trial of preventive angioplasty in myocardial infarction [J].N Engl J Med,2013,369(12):1115-1123.
[18] Gershlick AH, Khan JN, Kelly DJ,et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial[J]. J Am Coll Cardiol,2015,65(10):963-972.
[19] Mylotte D,Morice MC,Eltchaninoff H,et al.Primary percutaneous coronary intervention in patients with acute myocardial infarction, resuscitated cardiac arrest, and cardiogenic shock: the role of primary multivessel revascularization[J]. JACC Cardiovasc Interv,2013,6(2):115-125.
[20] Kereiakes DJ.Reassessing the importance of complete versus incomplete coronary revascularization[J].Rev Cardiovasc Med,2014,15(1):24-30.
[21] Kowalewski M,Schulze V,Berti S,et al.Complete revascularisation in ST-elevation myocardial infarction and multivessel disease:meta-analysis of randomised controlled trials[J]. Heart,2015,101(16):1309-1317.
[22] Levine GN, Bates ER,Blankenship JC, et al.2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J]. Circulation,2016,133(11):1135-1147.
[23] Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention:a report of the American College of Cardiology Foundation/Amercian Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions[J].Circulation,2011,124(23):e574-e651.
[24] Hlinomaz O. Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy: the PRAGUE 13 trial. Presented at: EuroPCR, 2015, Paris, France.
[25] Kornowski R, Mehran R, Dangas G, et al.Prognostic impact of staged versus “one-time” multivessel percutaneous intervention in acute myocardial infarction:analysis from the HORIZONS-AMI(harmonizing outcomes with revascularization and stents in acute myocardial infarction)trial[J].J Am Coll Cardiol,2011,58(7):704-711.
[26] Engstrøm T, Kelbæk H,Helgvist S,et al.Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease(DANAMI-3 PRIMULTI): an open-label, randomised controlled trial[J]. Lancet,2015,386(9994):665-671.
[27] Manari A,Varani E,Guastaroba P,et al.Long-term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit-only, immediate, or staged multivessel percutaneous revascularization strategies:insights from the REAL registry[J].Catheter Cardiovasc Interv,2014,84:912-922.
[28] Kakura K,Ako J,Wada H,et al.Comparison of the resource utilization between simultaneous strategy and staged strategy to treat two-vessel coronary artery disease by percutaneous coronary intervention[J].J Invasive Cardiol,2011,23(11):454-459.
[29] Mario CD,Rosser D. Open questions for non-infarct-related arteries in STEMI.www.thelancet.com,Published online August 5,2015:http://dx.doi.org/10.1016/S0140-6736(15)60856-X.
相似文献/References:
[1]郭君君,郑宏超,曹阳.生物标志物对急性心肌梗死介入治疗预后的预测意义[J].心血管病学进展,2016,(1):37.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.010]
GUO Junjun,ZHENG Hongchao,CAO Yang.Prognostic Significance of Biomarkers in Predicting Acute Myocardial
Infarction after Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2016,(3):37.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.010]
[2]林远龙,刘现亮.无复流现象:从基础到临床[J].心血管病学进展,2016,(1):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
LIN Yuanlong,LIU Xianliang.From Bench to Bed:No-reflow Phenomenon[J].Advances in Cardiovascular Diseases,2016,(3):53.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.014]
[3]杨立华,综述,钟国强,等.经皮冠状动脉介入术后患者抑郁变化的研究进展[J].心血管病学进展,2016,(3):299.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.022]
YANG Lihua,ZHONG Guoqiang.Advance in Change of Depression in Patients Receiving Percutaneous
Coronary Intervention[J].Advances in Cardiovascular Diseases,2016,(3):299.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.022]
[4]余正春,综述,马小静,等.急性心肌梗死并发心源性休克的治疗进展[J].心血管病学进展,2016,(4):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
YU Zhengchun,MA Xiaojing.Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2016,(3):441.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.029]
[5]刘强,杨小梅,韩乾国.冠状动脉钙化研究进展[J].心血管病学进展,2015,(5):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
LIU Qiang,YANG Xiaomei,HAN Qianguo.Progress in Clinical Application of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2015,(3):651.[doi:10.3969/j.issn.1004-3934.2015.05.033]
[6]魏恒争,木胡牙提.比伐卢定在急性冠状动脉综合征患者PCI中的应用进展[J].心血管病学进展,2015,(6):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
WEI Hengzheng,MUHU Yati.Advance in Research of Bivalirudin During Percutaneous Coronary Intervention
in Patients with Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2015,(3):725.[doi:10.3969/j.issn.1004-3934.2015.06.017]
[7]袁帅,毛玉琳,钱志敏,等.经皮冠脉介入术在高龄老年患者治疗中的研究新进展[J].心血管病学进展,2019,(6):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
YUAN Shuai,MAO Yulin,QIAN Zhimin,et al.New Progress in Study of PCI in treatment of Elderly Patients[J].Advances in Cardiovascular Diseases,2019,(3):864.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.007]
[8]元洋洋 李波.Selvester QRS评分系统研究进展[J].心血管病学进展,2019,(7):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
YUAN YangyangLI Bo.Research Progress of Selvester QRS Scoring System[J].Advances in Cardiovascular Diseases,2019,(3):985.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.005]
[9]翁子骞 于波.血栓抽吸在急性ST段抬高型心肌梗死中的研究进展[J].心血管病学进展,2019,(7):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
WENG ZiqianYU Bo.Thrombus aspiration in acute ST-segment elevation myocardial infarction[J].Advances in Cardiovascular Diseases,2019,(3):1035.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.018]
[10]林莉 韦铁民.急性心肌梗死后心脏破裂[J].心血管病学进展,2019,(7):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]
LIN LiWEI Tiemin.Post-infarction Cardiac Rupture[J].Advances in Cardiovascular Diseases,2019,(3):1039.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.019]